Clinical Trial Update: Tuberculosis (TB) Immunotherapy Phase 2 Study [Phase 2]

View source ↗

Summary

Phase 2 tuberculosis immunotherapy trial sponsored by Lisichansk Regional Tuberculosis Dispensary has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: Lisichansk Regional Tuberculosis Dispensary | Conditions: Tuberculosis | Phase 2 | Status: COMPLETED